The Analysis of Predictive Factors for the Identification of Patients Who Could Benefit from Respiratory-Gated Radiotherapy in Non-Small Cell Lung Cancer.
10.3857/jkstro.2009.27.4.228
- Author:
Seong Soon JANG
1
;
Ji Chan PARK
Author Information
1. Department of Radiation Oncology, College of Medicine, The Catholic University of Korea, Seoul, Korea. ssjang@catholic.ac.kr
- Publication Type:Original Article
- Keywords:
Non-small cell lung cancer;
Respiratory-gated radiotherapy;
4DCT
- MeSH:
Carcinoma, Non-Small-Cell Lung;
Humans;
Lung;
Retrospective Studies;
Tumor Burden
- From:The Journal of the Korean Society for Therapeutic Radiology and Oncology
2009;27(4):228-239
- CountryRepublic of Korea
- Language:Korean
-
Abstract:
PURPOSE: 4DCT scans performed for radiotherapy were retrospectively analyzed to assess the possible benefits of respiratory gating in non-small cell lung cancer (NSCLC) and established the predictive factors for identifying patients who could benefit from this approach. MATERIALS AND METHODS: Three treatment planning was performed for 15 patients with stage I~III NSCLC using different planning target volumes (PTVs) as follows: 1) PTVroutine, derived from the addition of conventional uniform margins to gross tumor volume (GTV) of a single bin, 2) PTVall phases (patient-specific PTV), derived from the composite GTV of all 6 bins of the 4DCT, and 3) PTVgating, derived from the composite GTV of 3 consecutive bins at end-exhalation. RESULTS: The reductions in PTV were 43.2% and 9.5%, respectively, for the PTVall phases vs. PTVroutine and PTVgating vs. PTVall phases. Compared to PTVroutine, the use of PTVall phases and PTVgating reduced the mean lung dose (MLD) by 18.1% and 21.6%, and V20 by 18.2% and 22.0%, respectively. Significant correlations were seen between certain predictive factors selected from the tumor mobility and volume analysis, such as the 3D mobility vector, the reduction in 3D mobility and PTV with gating, and the ratio of GTV overlap between 2 extreme bins and additional reductions in both MLD and V20 with gating. CONCLUSION: The additional benefits with gating compared to the use of patient-specific PTV were modest; however, there were distinct correlations and differences according to the predictive factors. Therefore, these predictive factors might be useful for identifying patients who could benefit from respiratory-gated radiotherapy.
